Evaluating mortality prediction in cardiac surgery using two scoring systems
Correlation of the European System for Cardiac Operative Risk Evaluation-II (EUROSCORE-II) With Preoperative Score to Predict Post-Operative Mortality (POSPOM) in Cardiac Surgery: A Single Center, Retrospective, Cross- Sectional Study
Istanbul University - Cerrahpasa · NCT06770738
This study is trying to see if two scoring systems can help predict the risk of death for patients having heart surgery at Istanbul University-Cerrahpasa.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 315 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06770738 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the correlation between the EUROSCORE-II and POSPOM scoring systems in predicting mortality rates for patients undergoing cardiac surgery at Istanbul University-Cerrahpasa. It will involve a retrospective analysis of patients who have undergone CABG or valve surgery between 2020 and 2024, focusing on various postoperative complications. The study will record outcomes such as re-sternotomy, transient ischemic attacks, and infections to evaluate the effectiveness of these scoring systems in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 and over who are scheduled for CABG or valve surgery with cardiopulmonary bypass.
Not a fit: Patients under 18, those undergoing off-pump surgery, or non-cardiac vascular surgeries will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve preoperative risk assessment and management strategies for cardiac surgery patients, potentially reducing mortality rates.
How similar studies have performed: While the EUROSCORE-II is widely used, the comparative effectiveness of EUROSCORE-II and POSPOM in this specific context is less established, making this study a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 and over, patients who have CABG surgery, valve surgery or both, and patients with on-pump surgery will be included in the study. Exclusion Criteria: * . Patients under the age of 18, patients with off-pump surgery, and patients with non-cardiac vascular surgery will be excluded from the study.
Where this trial is running
Istanbul
- Istanbul University- Cerrahpasa — Istanbul, Turkey (RECRUITING)
Study contacts
- Principal investigator: Kerem Erkalp, Dr — Professor
- Study coordinator: Gozde Altun, Dr
- Email: gozde.altun@iuc.edu.tr
- Phone: +905544290333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiac Disease, Cardiovascular Diseases, Cardiovascular Complication, Anesthesia, Perioperative/Postoperative Complications, Surgery